RAPT Therapeutics (FRA:0RA) Ending Cash Position : €34.45 Mil (As of Jun. 2024)

View and export this data going back to 2019. Start your Free Trial

What is RAPT Therapeutics Ending Cash Position?

RAPT Therapeutics's Ending Cash Position for the quarter that ended in Jun. 2024 was €34.45 Mil.

RAPT Therapeutics's quarterly Ending Cash Position declined from Dec. 2023 (€43.54 Mil) to Mar. 2024 (€41.69 Mil) and declined from Mar. 2024 (€41.69 Mil) to Jun. 2024 (€34.45 Mil).

RAPT Therapeutics's annual Ending Cash Position increased from Dec. 2021 (€21.26 Mil) to Dec. 2022 (€36.77 Mil) and increased from Dec. 2022 (€36.77 Mil) to Dec. 2023 (€43.54 Mil).

RAPT Therapeutics Ending Cash Position Historical Data

The historical data trend for RAPT Therapeutics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RAPT Therapeutics Ending Cash Position Chart

RAPT Therapeutics Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

69.65

20.48

21.26

36.77

43.54

RAPT Therapeutics Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Ending Cash Position	Get a 7-Day Free Trial															46.30	50.72	43.54	41.69	34.45

RAPT Therapeutics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

RAPT Therapeutics's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	35.713	+	7.824
	=	43.54

RAPT Therapeutics's Ending Cash Position for the quarter that ended in Jun. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	42.1	+	-7.655
	=	34.45

RAPT Therapeutics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of RAPT Therapeutics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

RAPT Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RAPT Therapeutics Inc (FRA:0RA) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

RAPT:USA

Address

561 Eccles Avenue, South San Francisco, CA, USA, 94080

Website

https://www.rapt.com

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

RAPT Therapeutics Headlines

No Headlines